Nanosphere develops molecular diagnostic tests and markets its products under the Verigene system brand. Over the last three years, Nanosphere’s revenue has increased by a factor of four. This company has positioned itself to leverage the growing molecular diagnostic industry. It recently received FDA clearance for an enteric test that should act as a huge growth catalyst, but the market has punished it severely instead. … Read more
Inuvo, Inc (INUV) went through a painful corporate restructuring process in recent years. Over the last 24 months, it has demonstrated compelling growth prospects and has reached profitability. We believe this microcap turnaround company will continue to grow and has substantial potential to deliver value to investors.
Inuvo, Inc., is an Internet marketing and technology company. It is engaged in developing cloud based software and analytics technology for online advertisers and website publishers.… Read more
When Cryoport Inc (CYRX) went public in March, 2005, it was trading at US$ 50.80 per share. It was based on the promise that Cryoport would become the market leader in frozen shipping logistics solution to the biotechnology and life science industries. Back then, Cyroport’s solution were disruptive to the established technologies in the frozen shipping segment.
Shipments of biological materials had been frozen in dry ice, which often required re-icing during transit.… Read more